Iron oxide nanoparticles-driven mitochondrial renewal rejuvenates the aged bone marrow niche.

Xiaoqing Sun, Xingyou Wang, Meihua Zhang, Shuyao Liu, Yue Zhu, Jing He, Yao Wu

National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610064, China.National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610064, China. · pubmed

Paper

Abstract

With the aging population, treating age-related osteoporosis remains challenging due to the dysfunctional bone marrow microenvironment characterized by chronic inflammation, metabolic dysregulation, and impaired mitochondrial function in senescent cells. While mitochondrial transfer from macrophages to bone marrow mesenchymal stem cells (BMSCs) offers a promising therapeutic avenue, its efficacy is limited in aged niches where donor mitochondria exhibit functional deficits and poor recipient compatibility. We engineered KGM-PEG-SPIONs, functionalized Fe

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that iron oxide nanoparticles can rejuvenate the aged bone marrow niche by enhancing mitochondrial function. This research is relevant as it addresses the root causes of aging-related dysfunction in the bone marrow microenvironment, specifically targeting mitochondrial impairment and chronic inflammation, which are critical factors in age-related diseases like osteoporosis.

Author of this paper? Send a correction.